SkyePharma PLC (SKP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

SkyePharma PLC (SkyePharma) is an oral and inhalation drug delivery company. It identifies, develops, manufactures and markets prescription oral and inhalation pharmaceutical products.

SkyePharma PLC Key Recent Developments

Oct 10, 2013: SkyePharma Announces Interim Management Statement
Oct 10, 2013: Skyepharma Publishes Interim Management Statement
Aug 22, 2013: Skyepharma appoints Andrew Derodra as Chief Financial Officer
Aug 23, 2012: SkyePharma Reports Revenue Of £19.8m In H1 2012
Apr 11, 2012: Skyepharma Announces Second Inhalation Development Contract With Respivert

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
SkyePharma PLC - Key Facts 5
SkyePharma PLC - Key Employees 6
SkyePharma PLC - Key Employee Biographies 7
SkyePharma PLC - Major Products and Services 8
SkyePharma PLC - Medical Equipment Pipeline Products Data 9
SkyePharma PLC Pipeline Products by Equipment Type 9
SkyePharma PLC Pipeline Products by Development Stage 10
SkyePharma PLC - Pharmaceutical Pipeline Products Data 11
SkyePharma PLC, Pipeline Products by Therapy Area 11
SkyePharma PLC, Pipeline Products by Development Phase 12
SkyePharma PLC - History 43
SkyePharma PLC - Company Statement 45
SkyePharma PLC - Locations And Subsidiaries 47
Head Office 47
Other Locations and Subsidiaries 47
SkyePharma PLC - Key Manufacturing Facilities 48
Section 2 - Company Analysis 49
SkyePharma PLC - Business Description 49
SkyePharma PLC - Corporate Strategy 51
SkyePharma PLC - SWOT Analysis 52
SWOT Analysis - Overview 52
SkyePharma PLC - Strengths 52
Strength - Geographical Diversity 52
Strength - Research and Development 52
Strength - Proprietary Technologies 52
SkyePharma PLC - Weaknesses 52
Weakness - Financial Performance 52
Weakness - Inventory Levels 53
SkyePharma PLC - Opportunities 53
Opportunity - Flutiform 53
Opportunity - Partnerships 53
Opportunity - Pharmerging Economies 53
SkyePharma PLC - Threats 54
Threat - Stringent Government Regulations 54
Threat - Competitive Atmosphere 54
Threat - Technological Advancements 54
SkyePharma PLC - Key Competitors 55
Section 3 - Company Financial Ratios 56
Financial Ratios - Capital Market Ratios 56
Financial Ratios - Annual Ratios 56
Performance Chart 58
Financial Performance 58
Financial Ratios - Interim Ratios 59
Financial Ratios - Ratio Charts 60
Section 4 - Company’s Lifesciences Financial Deals and Alliances 61
SkyePharma PLC, Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 61
SkyePharma PLC, Pharmaceuticals and Healthcare, Deals By Type, 2007 to YTD 2013 62
SkyePharma PLC, Medical Equipment, Deals By Year, 2007 to YTD 2013 63
SkyePharma PLC, Medical Equipment, Deals By Type, 2007 to YTD 2013 64
SkyePharma PLC, Recent Deals Summary 65
Section 5 - Company’s Recent Developments 66
SkyePharma PLC, Recent Developments 66
Oct 10, 2013: SkyePharma Announces Interim Management Statement 66
Oct 10, 2013: Skyepharma Publishes Interim Management Statement 67
Aug 22, 2013: Skyepharma appoints Andrew Derodra as Chief Financial Officer 69
Aug 23, 2012: SkyePharma Reports Revenue Of £19.8m In H1 2012 70
Mar 21, 2012: SkyePharma Reports Revenue Of £55.2m In 2011 70
Jan 10, 2012: SkyePharma Announces Reorganization Of Swiss Operations 70
Section 6 - Appendix 71
Methodology 71
Ratio Definitions 71
About GlobalData 75
Contact Us 75
Disclaimer 75

List of Tables

SkyePharma PLC, Key Facts 5
SkyePharma PLC, Key Employees 6
SkyePharma PLC, Key Employee Biographies 7
SkyePharma PLC, Major Products and Services 8
SkyePharma PLC Number of Pipeline Products by Equipment Type 9
SkyePharma PLC Pipeline Products by Equipment Type 9
SkyePharma PLC Number of Pipeline Products by Development Stage 10
SkyePharma PLC Pipeline Products by Development Stage 10
SkyePharma PLC, Number of Pipeline Products by Therapy Area 11
SkyePharma PLC, Number of Pipeline Products by Development Stage 12
SkyePharma PLC, Pipeline Products By Therapy Area and Development Phase 13
SkyePharma PLC, History 43
SkyePharma PLC, Subsidiaries 47
SkyePharma PLC, Key Manufacturing Facilities 48
SkyePharma PLC, Key Competitors 55
SkyePharma PLC, Ratios based on current share price 56
SkyePharma PLC, Annual Ratios 56
SkyePharma PLC, Interim Ratios 59
SkyePharma PLC, Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 61
SkyePharma PLC, Pharmaceuticals and Healthcare, Deals By Type, 2007 to YTD 2013 62
SkyePharma PLC, Medical Equipment, Deals By Year, 2007 to YTD 2013 63
SkyePharma PLC, Medical Equipment, Deals By Type, 2007 to YTD 2013 64
SkyePharma PLC, Recent Deals Summary 65
Currency Codes 71
Capital Market Ratios 71
Equity Ratios 72
Profitability Ratios 72
Cost Ratios 73
Liquidity Ratios 73
Leverage Ratios 74
Efficiency Ratios 74

List of Figures

SkyePharma PLC Pipeline Products by Equipment Type 9
SkyePharma PLC Pipeline Products by Development Stage 10
SkyePharma PLC, Pipeline Products by Therapy Area 11
SkyePharma PLC, Pipeline Products by Development Phase 12
SkyePharma PLC, Performance Chart (2008 - 2012) 58
SkyePharma PLC, Ratio Charts 60
SkyePharma PLC, Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 61
SkyePharma PLC, Pharmaceuticals and Healthcare, Deals by Type, 2007 to YTD 2013 62
SkyePharma PLC, Medical Equipment, Deals By Year, 2007 to YTD 2013 63
SkyePharma PLC, Medical Equipment, Deals by Type, 2007 to YTD 2013 64

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

M2M device connections and revenue: worldwide forecast 2014-2024

M2M device connections and revenue: worldwide forecast 2014-2024

  • $ 7 999
  • Industry report
  • July 2014
  • by Analysys Mason

About this report This report presents the bi-annual update to our forecast for machine-to-machine (M2M) connections. It provides a detailed 10-year worldwide forecast, for eight regions, of: -M2M device ...

The M2M device connections and revenue: worldwide forecast 2014-2024

The M2M device connections and revenue: worldwide forecast 2014-2024

  • $ 7 999
  • Industry report
  • July 2014
  • by Analysys Mason

Machine-to-machine (M2M) represents a strong growth market across various industry segments. The market will grow to 3.2 billion connections worldwide by 2024, at a CAGR of 28%. Smart meters and connected ...

The Market for Thermal Management Technologies

The Market for Thermal Management Technologies

  • $ 6 650
  • Industry report
  • March 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for thermal management products is expected to grow from about $10.1 billion in 2013 to $10.6 billion in 2014 and $14.7 billion by 2019, a compound annual growth rate ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.